噻唑烷二酮
过氧化物酶体增殖物激活受体
转录因子
生物
核受体
PPAR激动剂
脂肪组织
细胞生物学
罗格列酮
调节器
过氧化物酶体
受体
内分泌学
生物化学
基因
2型糖尿病
糖尿病
作者
Peter Tontonoz,Bruce M. Spiegelman
标识
DOI:10.1146/annurev.biochem.77.061307.091829
摘要
The nuclear receptor PPARgamma is a ligand-activated transcription factor that plays an important role in the control of gene expression linked to a variety of physiological processes. PPARgamma was initially characterized as the master regulator for the development of adipose cells. Ligands for PPARgamma include naturally occurring fatty acids and the thiazolidinedione (TZD) class of antidiabetic drugs. Activation of PPARgamma improves insulin sensitivity in rodents and humans through a combination of metabolic actions, including partitioning of lipid stores and the regulation of metabolic and inflammatory mediators termed adipokines. PPARgamma signaling has also been implicated in the control of cell proliferation, atherosclerosis, macrophage function, and immunity. Here, we review recent advances in our understanding of the diverse biological actions of PPARgamma with an eye toward the expanding therapeutic potential of PPARgamma agonist drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI